Kronos Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.40
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.65
|
-0.57
|
0.08
|
12.31%
|
|
2022-06-30
|
-0.69
|
-0.59
|
0.10
|
14.49%
|
|
2022-03-31
|
-0.66
|
-0.65
|
0.01
|
1.52%
|
|
2021-12-31
|
-1.10
|
-1.13
|
-0.03
|
-2.73%
|
|
2021-09-30
|
-1.01
|
-0.61
|
0.40
|
39.60%
|
|
2021-06-30
|
-0.62
|
-0.53
|
0.09
|
14.52%
|
|
2021-03-31
|
-0.43
|
-0.48
|
-0.05
|
-11.63%
|
|
2020-12-31
|
-0.79
|
-0.70
|
0.09
|
11.39%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.81
|
|
2021-12-31
|
-2.75
|
|
2020-12-31
|
-7.73
|